- Home
- BLZE vs RIGL Comparison
BLZE vs RIGL Comparison
Compare BLZE & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- RIGL
- Stock Information
- Founded
- BLZE 2007
- RIGL 1996
- Country
- BLZE United States
- RIGL United States
- Employees
- BLZE N/A
- RIGL N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- RIGL Biotechnology: Pharmaceutical Preparations
- Sector
- BLZE Technology
- RIGL Health Care
- Exchange
- BLZE Nasdaq
- RIGL Nasdaq
- Market Cap
- BLZE 310.6M
- RIGL 486.4M
- IPO Year
- BLZE 2021
- RIGL 2000
- Fundamental
- Price
- BLZE $6.10
- RIGL $17.32
- Analyst Decision
- BLZE Strong Buy
- RIGL Buy
- Analyst Count
- BLZE 4
- RIGL 5
- Target Price
- BLZE $11.50
- RIGL $34.80
- AVG Volume (30 Days)
- BLZE 312.8K
- RIGL 316.4K
- Earning Date
- BLZE 02-13-2025
- RIGL 11-07-2024
- Dividend Yield
- BLZE N/A
- RIGL N/A
- EPS Growth
- BLZE N/A
- RIGL N/A
- EPS
- BLZE N/A
- RIGL 0.22
- Revenue
- BLZE $122,579,000.00
- RIGL $157,374,000.00
- Revenue This Year
- BLZE $27.53
- RIGL $48.98
- Revenue Next Year
- BLZE $14.73
- RIGL $14.43
- P/E Ratio
- BLZE N/A
- RIGL $78.31
- Revenue Growth
- BLZE 27.41
- RIGL 21.65
- 52 Week Low
- BLZE $4.91
- RIGL $7.48
- 52 Week High
- BLZE $12.65
- RIGL $29.82
- Technical
- Relative Strength Index (RSI)
- BLZE 38.33
- RIGL 38.25
- Support Level
- BLZE $5.98
- RIGL $15.61
- Resistance Level
- BLZE $6.50
- RIGL $17.36
- Average True Range (ATR)
- BLZE 0.29
- RIGL 1.31
- MACD
- BLZE -0.06
- RIGL -0.25
- Stochastic Oscillator
- BLZE 9.23
- RIGL 50.75
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.